Xu K - Search Results

1

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.

Jiang H, Zhu Y, Zhou Z, Xu J, Jin S, Xu K, Zhang H, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: xu k, xu j. Cancer Med. 2018 Mar;7(3):869-882. doi: 10.1002/cam4.1360. Epub 2018 Feb 14. Cancer Med. 2018. PMID: 29441724 Free PMC article.

2

High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.

He C, Xu J, Zhang J, Xie D, Ye H, Xiao Z, Cai M, Xu K, Zeng Y, Li H, Wang J. He C, et al. Among authors: xu k, xu j. Hum Pathol. 2012 Sep;43(9):1425-35. doi: 10.1016/j.humpath.2011.11.003. Epub 2012 Mar 9. Hum Pathol. 2012. PMID: 22406368

3

Is the end of the T-tube drainage era in laparoscopic choledochotomy for common bile duct stones is coming? A systematic review and meta-analysis.

Yin Z, Xu K, Sun J, Zhang J, Xiao Z, Wang J, Niu H, Zhao Q, Lin S, Li Y. Yin Z, et al. Among authors: xu k. Ann Surg. 2013 Jan;257(1):54-66. doi: 10.1097/SLA.0b013e318268314b. Ann Surg. 2013. PMID: 23059495 Review.

4

PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.

Zhang Y, Zhang J, Xu K, Xiao Z, Sun J, Xu J, Wang J, Tang Q. Zhang Y, et al. Among authors: xu k, xu j. Hepatogastroenterology. 2013 Oct;60(127):1766-72. Hepatogastroenterology. 2013. PMID: 24624456

5

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma.

Jin S, Wang K, Xu K, Xu J, Sun J, Chu Z, Lin D, Koeffler PH, Wang J, Yin D. Jin S, et al. Among authors: xu k, xu j. Oncotarget. 2014 Jun 15;5(11):3685-96. doi: 10.18632/oncotarget.1986. Oncotarget. 2014. PMID: 25003523 Free PMC article.

6

Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.

Mao K, Zhang J, He C, Xu K, Liu J, Sun J, Wu G, Tan C, Zeng Y, Wang J, Xiao Z. Mao K, et al. Among authors: xu k. Cancer Lett. 2014 Oct 1;352(2):245-52. doi: 10.1016/j.canlet.2014.07.004. Epub 2014 Jul 14. Cancer Lett. 2014. PMID: 25034398

7

Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence.

He C, Zhou Z, Jiang H, Yin Z, Meng S, Zhang J, Huang P, Xu K, Bian L, Xiao Z, Wang J. He C, et al. Among authors: xu k. J Cancer. 2017 Jan 1;8(1):39-47. doi: 10.7150/jca.16736. eCollection 2017. J Cancer. 2017. PMID: 28123596 Free PMC article.

8

Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection.

Hu Z, Li W, Huang P, Zhou Z, Xu J, Xu K, Wang J, Zhang H. Hu Z, et al. Among authors: xu k, xu j. Int J Surg. 2017 Dec;48:23-31. doi: 10.1016/j.ijsu.2017.09.075. Epub 2017 Oct 5. Int J Surg. 2017. PMID: 28987561 Free article.

9

PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.

Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: xu k, xu j. Cancer Sci. 2018 May;109(5):1414-1427. doi: 10.1111/cas.13598. Cancer Sci. 2018. PMID: 29603830 Free PMC article.

10

Ropivacaine via nuclear factor kappa B signalling modulates CD62E expression and diminishes tumour cell arrest.

Su Z, Huang P, Ye X, Huang S, Li W, Yan Y, Xu K, Wang J, Chen R. Su Z, et al. Among authors: xu k. J Anesth. 2019 Dec;33(6):685-693. doi: 10.1007/s00540-019-02699-1. Epub 2019 Oct 23. J Anesth. 2019. PMID: 31642986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,602 results

Search Page

Filters